Latest Seizure Stories
Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted—in fact, it is dramatically underutilized according to a new study from the University of California, San Francisco (UCSF).
A new type of anti-epilepsy medication that selectively targets proteins in the brain that control excitability may significantly reduce seizure frequency in people whose recurrent seizures have been resistant to even the latest medications.
Based on their clinical experience and observations, a team of Johns Hopkins physicians and psychologists say that more than one-third of the patients admitted to The Johns Hopkins Hospital's inpatient epilepsy monitoring unit for treatment of intractable seizures have been discovered to have stress-triggered symptoms rather than a true seizure disorder.
Long-awaited Institute of Medicine Committee Report will address the broader spectrum of issues affecting those living with epilepsy Los Angeles, CA and Washington
A portion of the grant funding raised at the local Foundation's annual Care and Cure Benefit will support UCSF postdoctoral fellow Jiadong Chen’s clinical training and research to aid in
Early-initiated immunotherapy appears to be associated with improved seizure outcomes among patients with autoimmune epilepsy.
- A poem in which the author retracts something said in an earlier poem.